Pharma Industry News

Researchers hail “exciting results” in ovarian, lung cancer trial

A chemo/targeted drug combination being trialed by UK researchers has shown promise in patients with advanced ovarian or lung cancer in whom all other treatments have failed.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]